Part 11 Compliant Data Management: Doing it Right in the Real World

Presented by Russell Barbare; Tuesday, April 2, 2013; 1:00pm to 2:30pm EDT (GMT -4)

FDA requires your investigational drug or medical device data to comply with all of the provisions of 21 CFR Part 11. But how can you generate compliant, reliable data in today’s environment of fewer staff, a disappearing consulting budget and little time for training?

Correctly managing drug or medical device data takes a variety of resources that sponsors, especially smaller firms, rarely have entirely in-house. But business has to run on a realistic budget. How can you balance the necessary requirements with the cost of compliance?

A key tool to minimizing costs and regulatory risks is to find your data management resource gaps...and efficiently fill them.

On Tuesday, April 2 beginning at 1:00pm EDT, join FOI as Russell Barbare, Clinical Operations Manager with Ofni Systems, presents a 90-minute discussion of how to evaluate the skill sets you already have in place for drug or medical device data management – and how you can leverage this knowledge to identify and fill compliance gaps. You’ll hear practical advice on how to implement potential solutions and down-to-earth suggestions for maintaining necessary control in your clinical process.

What You'll Learn:

What You'll Get:

Who Should Attend:

About The Speaker:

Russell Barbare has spent over decade of experience in clinical trial data management, first as a Data Management Specialist with Gad Consulting Services and subsequently moving to his current position as Clinical Operations Manager with Ofni Systems Inc. This experience has contributed to a large number of successful regulatory filings, covering aspects of development from INDs/IDEs to NDAs/PMAs. Russell has worked on virtually every aspect of clinical data management, including study data collection plans; site and lab auditing; database design and implementation; clinical data software design; regulatory compliance including 21 CFR Part 11 and GxP implementation; data cleaning and extraction; safety, efficacy, and pharmacokinetic analysis; report writing and regulatory submissions. If you would like to know more about the coverage of this presentation, you are invited to contact Russell directly at

How It Works:

Each toll-free (even if international) dial in is $449; put the teleconference on your speakerphone and have as many attendees as you like for this price. FOI Services will provide a handout 1-2 days before the teleconference. The materials may be duplicated for anyone attending.


Tuesday, April 2, 2013; 1:00pm-2:30pm EDT (GMT -4)


In your office or conference room